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EpidemiologyMeasurements of estrogenic and androgenic activities in total plasmawith Chemically Activated LUciferase gene
eXpression (CALUX®) bioassays could provide biologically relevant measures for exposure to endocrine
disruptors in epidemiologic studies. The objective of this studywas to explore the effects of a variety of sources of
potential endocrine disruptors on estrogenic and androgenic activities in total plasma measured by CALUX®.
Plasma samples and interview data on sources of potential endocrine disruptors were collected from 108 men
with different exposures proﬁles. CALUX® measurements (BioDetection Services) involved human U2-OS cell
lines controlled by the estrogen receptor alpha and the androgen receptor. Mean differences (beta) in 17β-
estradiol equivalents (EEQs) and dihydrotestosterone equivalents (AEQs) between exposure groups were
estimated using general linear models. Mean plasma AEQs and EEQs were 9.1×10−1 ng/ml and 12.0 pg/ml,
respectively. Elevated AEQs were found in smokers (beta 1.9 (95%CI 0.1–3.6)×10−1 ng/ml) and heavy drinkers
(1.4 (0.2–3.1)×10−1 ng/ml), and inmenoccupationally exposed todisinfectants (1.6 (0.3–3.5)×10−1 ng/ml) or
welding/soldering fumes (1.4 (−0.2–2.9)×10−1 ng/ml). Occupational exposure to pesticides, disinfectants, and
exhaust fumes seemed to be associated with increased plasma EEQs: 1.5 (−0.2–3.2)pg/ml, 2.1 (0.2–3.9)pg/ml,
and 2.9 (0.6–5.2)pg/ml, respectively. Moderate to high plasma dioxin levels, measured in a subgroup by the
dioxin-responsive CALUX®,were accompanied by a 20% increase inAEQs. This is theﬁrst study inwhich CALUX®
was used to assess hormone activities in total plasma. Although the results are not yet readily interpretable, they
indicate that these measurements can be valuable for epidemiologic studies on endocrine disruptors and give
direction for further research.gional Committee on Research
, Biostatistics, and HTA (133),
9101 6500 HB Nijmegen, The
05.
eld).
vier OA license.© 2010 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Endocrine disruptors are described as exogenous substances that
alter functions of the endocrine system and consequently cause
adverse health effects in organisms and/or their progeny (Damstra
et al., 2002). A growing list of substances are now suspected of such
endocrine disrupting properties, including industrial chemicals, such
as polycyclic aromatic hydrocarbons (PAHs) (Arcaro et al., 1999),
dioxins (Department of Health and Human Services Centers for
Disease Control and Prevention, 2005), brominated ﬂame retardants(Birnbaum and Staskal, 2004), several pesticides (Bretveld et al.,
2007), bisphenol A (Mafﬁni et al., 2006), phthalates (Lottrup et al.,
2006), parabens (Harvey and Darbre, 2004), organic solvents (Luderer
et al., 2004), and some metals (Queiroz and Waissmann, 2006), as
well as the naturally occurring phytoestrogens (North and Golding,
2000). Exposure to these substances occurs in everyday life and
involves very different sources, such as diet, personal care products,
tobacco smoke, and exposures at the workplace. Endocrine disruptors
may interfere with the endocrine system through activating or
blocking hormone receptors, but they can also alter the synthesis,
metabolism, and clearance of endogenous hormones and thereby
inﬂuence hormone bioavailability (Damstra et al., 2002). Endocrine
disruptors are hypothesized to play a role in the pathogenesis of
various disorders, including urogenital birth defects, endometriosis,
male and female subfertility, and malignancies (Skakkebaek et al.,
2001; Heilier et al., 2005; Hess-Wilson and Knudsen, 2006; Darbre,
2006). However, epidemiological evidence for health risks of current
exposure levels is scarce.
Fig. 1. Graphic illustration of ER CALUX® and AR CALUX® measurements in total
plasma, as performed in the present study. CALUX U2-OS cells are exposed to total
plasma, which would contain a mixture of xenobiotics (X) and endogenous hormones
(H). Depending on their speciﬁc chemical properties, xenobiotics can remain bound to
proteins (X-PB) or lipids (X-LB). A large amount of the endogenous hormones normally
remain protein bound (H-PB) and are therefore biologically inactive. After uptake, both
endogenous hormones and xenobiotics may bind to hormone receptors (HR). These
receptor-ligand complexes may (or may not) activate transcription of hormone-
responsive elements (HRE) and the luciferase gene construct (Luc.), leading to the
release of luciferase, which is quantiﬁed by luminescence. In this model, elevated or
reduced luminescence may indicate interference of xenobiotics with the bioavailability
of endogenous hormones on a plasma level (1) and their ability to activate or block
hormone receptors within the target cell (2).
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developed that offer new possibilities for epidemiologic research into
endocrinedisruption, amongwhich theChemically Activated LUciferase
gene eXpression (CALUX®) bioassays (Murk et al., 1997; Sonneveld
et al., 2005). CALUX® bioassays constitute of a genetically modiﬁed cell
line in which speciﬁc receptor responsive DNA elements are linked to a
so-called reporter gene that transcribes to the easily measurable ﬁreﬂy
(Photinus pyralis) protein luciferase. In essence, CALUX® bioassays
measure receptor induced gene expression, which gives information
about the expected biological response to chemicals in humans. For
example, elevated or reduced gene expression measured with a
CALUX® bioassay indicates whether speciﬁc substances would exert
agonistic or antagonistic effects on the target cell level.
In epidemiological investigations, CALUX® technology has mostly
been used to assess internal exposure to dioxin-like substances
(Pauwels et al., 2001; Den Hond et al., 2002; Nawrot et al., 2002;
Koppen et al., 2002; Van Den Heuvel et al., 2002; Warner et al., 2005;
Ayotte et al., 2005; Dhooge et al., 2006). For that purpose, dioxin-
responsive cell lines (DR CALUX®) were developed in which
expression of luciferase is mediated by activation of the aryl
hydrocarbon receptor (AhR). CALUX® bioassays that are responsive
to estrogens (ER CALUX®) or androgens (AR CALUX®) seem
particularly interesting with respect to endocrine disruption of
reproductive hormones. So far, the ER CALUX® and AR CALUX®
have predominantly been used to study receptor-activating abilities
of individual chemicals (Meerts et al., 2001; Schreurs et al., 2005;
Hamers et al., 2006) or mixtures of chemicals in e.g. environmental
samples (Houtman et al., 2006; Van der Linden et al., 2008; Wenger
et al., 2008). In two epidemiologic studies, the ER CALUX® and AR
CALUX® were used to determine estrogenic and androgenic activities
of persistent organic pollutants (POPs) extracted from male serum
samples (Pliskova et al., 2005; Kruger et al., 2008). In addition, a
recent publication by Pederson and colleagues, describes ER CALUX®
and AR CALUX® measurements of maternal and fetal plasma samples
aftermethyl tert-butyl ether (MTBE) extraction, and their associations
with internal levels of dioxin-like substances (Pedersen et al., 2010).
To our knowledge, the ER CALUX® and AR CALUX® bioassays have
not previously been used to study estrogenic and androgenic activities
in total human plasma, containing all prevalent xenobiotics and
endogenous hormones (see Fig. 1). In this model, an elevated or
reduced estrogenic or androgenic activity could result from interference
of xenobiotics with the bioavailability of endogenous hormones and/or
their ability to activate or block hormone receptors within the cell. Such
measurements could provide biologically relevant summary estimates
for endocrine disruption.
Therefore, the objective of this study was to explore the effects of a
variety of sources of potential endocrine disruptors, including occupa-
tional exposures, smoking, personal care products, living environment,
and diet, as well as the effects of potential determinants such as age and
weight on the estrogenic and androgenic activities in total plasma
measured by CALUX® bioassays, which would provide ideas about the
applicability of these measurements for epidemiologic studies.
2. Materials and methods
2.1. Population
Subjects were selected from a population of men who participated
in a case–referent study on risk factors for hypospadias and
cryptorchidism. Cases with hypospadias and cryptorchidism were
compared to a referent population of boys with persistent middle ear
effusion, for which they received ear ventilation tubes. In 2005, the
fathers of cases and referents completed postal questionnaires
covering a wide range of potential risk factors, including exposure
to potential endocrine disruptors through diet, work, or leisure time
activities. Based on these questionnaire data, 135 fathers wereselected for the present study. Included were fathers who reported
speciﬁc occupational exposures (pesticides, paints, adhesives, thin-
ners, industrial cleaning agents, dry cleaning agents, metal exhaust
fumes, and fumes from plastics), regular use of personal care
products, or obesity at time of the index pregnancy. With respect to
dietary habits, we selected fathers with a high intake of ﬁsh (≥3 times
per week), as a major source of persistent endocrine disrupting
chemicals. Due to small numbers, we could not select a group of
fathers with regular intake of soy replacements for meat or dairy,
which are rich sources of phytoestrogens. A number of fathers who
did not report occupational exposures, had a low or average dietary
intake of ﬁsh, were not obese, and did not frequently use personal care
products was selected as well. The aim of this selection strategywas to
obtain a sufﬁcient exposure gradient in the study population to assess
differences between low and high exposure groups, expecting that the
exposures at time of pregnancy (4 to 11 years ago) would partly
correspond with current exposures of the fathers. The selected fathers
received an invitation letter and study information by regular mail
and were contacted by telephone to ask for their consent, which was
later conﬁrmed in writing. We chose to restrict the study population
to men, because the menstrual cycle in women would bring about
many methodological difﬁculties.2.2. Data collection
From February until April 2007, all study participants were visited
at home or at work for a single blood draw and interview. Participants
were asked to abstain from alcohol and drinks or foodstuffs that
Table 1
Mean, minimum, and maximum estrogenic (EEQ), androgenic (AEQ), and dioxin-like
(TEQ) activities measured in total plasma of the study participants.a
n Mean (SD) Minimum Maximum
EEQ pg/ml 108 12.1 (3.0) 5.2 21.0
AEQ×10−1 ng/ml 108 9.1 (2.9) 2.1 17.9
TEQ pg/g lipid 50 54.0 (12.9) 31.5 85.0
a Please note that the study population consisted of men with speciﬁc exposure
proﬁles and that blood was drawn at variable times during the day. Therefore, the
measured values are not readily generalisable to other men.
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lead to temporarily elevated levels of plasma phytoestrogens. Blood
(10 ml) was collected in glass heparin coated vacutainers and was
cooled in a closed box during transportation. After spinning, plasma
was stored in glass collection tubes and frozen at−80 °C until further
work up. Current exposures to and determinants for potential
endocrine disruptors were assessed with structured interviews, in
which we included questions on age, weight, ethnic origin, living
environment (urban vs. country side), smoking, personal care
products (used within the past two days), leisure time activities
(home improvements, hobbies), and speciﬁc occupational exposures
(see Table 3). Questions were phrased as: ‘Do you work with
pesticides, e.g. to control weeds, insects, or fungi?’ Subjects were
asked about exposure intensities (e.g. number of hours per week) and
when they were last exposed to speciﬁc agents. General questions
about tasks and activities at work were included as well. Referring to
the past 4 weeks, subjects scored their intake frequency of food items
such as seafood, chicken, beef, pork, or eggs, as sources of persistent
endocrine disrupting chemicals. In order to assess the long-term
effects of phytoestrogens, we collected data on the regular intake of
soy replacements for meat or dairy. Information on alcohol consump-
tion, health status, and prescriptive drug use was collected as well.
2.3. CALUX® measurements
CALUX® measurements were performed at BioDetection Systems
BV in Amsterdam, as described in detail elsewhere (Sonneveld et al.,
2005). Estrogenic and androgenic activities were determined using
human U2-OS cell lines stably transfected with a luciferase gene
construct that was controlled by the estrogen receptor alpha (ERα
CALUX®) and androgen receptor (AR CALUX®), respectively. The
microtiter plates in which the cells were plated contained calibration
concentration series of 17β-estradiol (ERα CALUX®) or dihydrotes-
tosterone (DHT) (AR CALUX®). Cells were exposed to a medium
containing human plasma with concentrations of 5% and 10% vol/vol,
and were incubated for 24 h under standard conditions.
For a subset of 50 men who were selected based on interview
information on weight, age, and dietary habits, dioxine-responsive
(DR) CALUX® measurements were performed, which provide an
indicator for internal total dioxins. These measurements were meant
to assess whether the effects of exposure sources that would involve
persistent endocrine disruptors could indeed be ascribed to a higher
body burden of such chemicals. A rat hepatoma H4IIE cell line was
used, which contains a luciferase reporter gene controlled by the AhR
(Murk et al., 1997).The microtiter plates contained a calibration
concentration series of 2,3,7,8-TCDD. Approximately 1 g of human
plasma was extracted by means of shake-solvent extraction (hexane:
diethylether, 97:3). The extract was cleaned through oxidation using
an acid silica column topped with sodium sulphate. DR CALUX® cells
were exposed to the cleaned extracts (0.8%DMSO) for 24 h.
Following the 24 h of incubation, media were removed and the
cells were lysed, after which a luciferin containing solution was added
to measure luminescence (Lucy2; Anthos Labtec Instruments, Wals,
Austria). Total estrogenic, androgenic, and dioxin-like activity in the
samples was determined by interpolation from the ﬁtted calibration
curves. Results were expressed as pg 17β-estradiol equivalents
(EEQs) and ng DHT equivalents (AEQs) per ml of processed plasma
and as pg 2,3,7,8-TCDD toxic equivalents (TEQs) per g of extracted
plasma lipid. Total sample lipid contents were determined gravimet-
rically. The limits of detection were for EEQs: 7.0 pg/ml plasma, for
AEQs: 0.42×10−1 ng/ml plasma, and for TEQs: 8.2 pg/g plasma lipid.
2.4. Data analyses
Statistical analyses were performed in SPPS version 16.0. Plasma
EEQs, AEQs, and TEQs were normally distributed. All exposurevariables and other determinants were classiﬁed into two or three
levels, of which one level was treated as the reference category (see
Tables 2–5). For the occupational exposure variables, the reference
category was restricted to fathers who did not report occupational
exposure to any of the exposure categories (n=34). Mean differences
in plasma EEQs and AEQs between variable categories were estimated
using general linear models with adjustment for time of blood draw to
account for diurnal variations in endogenous estradiol and testosterone
(Albertsson-Wikland et al., 1997; Diver et al., 2003). Multivariable
analyses were done to estimate the effect of each exposure variable
independently from potential confounders if at least 10 observations
per included dummy variable were available. All general determinants
and exposure variables presented in Table 2 and the summary variable
‘any occupational exposure’were treated as potential confounders. The
dietary exposure variables presented in Table 4 were not, in order to
prevent overcorrection. First, each of the potential confounders was
added to the model separately. Subsequently, confounders that
changed the crude beta with at least 10% were added to the model
simultaneously. The 10% rule was not applied when the crude effect
estimates of exposure variables were very weak (betas between−1.0
and 1.0 pg/ml EEQ, −1.0 and 1.0×10−1 ng/ml AEQs, and −5.0 and
5.0 pg/g lipid TEQ were considered weak effect estimates with regard
to the need to adjust for potential confounders); in these cases,we only
adjusted for confounders if this resulted in substantially stronger effect
estimates. A similar data analyses strategy was used to assess
associations between speciﬁc variables and internal dioxin levels
measured by the DR CALUX®.
3. Results
One hundred and eight men (80%) participated and provided plasma samples and
interview data. The time of blood draw varied between 8:00 am and 8:30 pm. The
mean, minimum, and maximum EEQs, AEQs, and TEQs measured in the total
population are shown in Table 1. Plasma total lipid levels of the subset of men who
were selected for the DR CALUX® measurements varied between 4.1 and 8.5 g/l.
Effect estimates for plasma EEQ and AEQ are displayed in Tables 2–4. The
regression coefﬁcients (beta) with 95% conﬁdence intervals (95%CI) reﬂect the mean
differences in EEQs and AEQs between the variable categories. The corresponding
intercepts varied between 12.8 and 16.2 pg/ml EEQ and 9.9 and 12.6×10−1 ng/ml AEQ
and were somewhat higher than the population means presented in Table 1 due to
adjustment for time of the blood draw.
As shown in Table 2, the four men of non-European origin (Turkish (n=1), Asian
(n=2), and Latin-American (n=1)), had3.1 (95%CI0.1–6.2)×10−1 ng/mlhigherplasma
AEQs compared to European Caucasianmen, indicating an approximately 30% higher total
plasma androgenic activity. In addition, men over 44 years of age seemed to have
somewhat higher plasma AEQs compared tomen younger than 40: beta 1.3 (95%CI−0.2–
2.7)×10−1 ng/ml. Smoking 10 or more cigarettes per day and drinking a minimum of 20
glasses of alcoholperweekwereassociatedwith increases inplasmaAEQsaswell: beta 1.9
(95%CI 0.1–3.6)×10−1 ng/ml and beta 1.4 (95%CI 0.2–3.1)×10−1 ng/ml, respectively.
Men who used prescriptive drugs were found to have 1.5 (95%CI 0.2–2.8)pg/ml higher
plasma EEQs, but this was difﬁcult to attribute to a speciﬁc type of drug. For BMI, weight
loss, use of personal care products, and living within a city centre, no clear associations
with plasma EEQs and AEQs were found.
Table 3 presents the effect estimates for occupational exposures. Reporting of any
occupational exposure seemedtobeassociatedwithan increase inplasmaEEQsof 1.2 (95%
CI−0.1–2.4)pg/ml. Exposure to pesticides appeared to be associated with an increase in
plasma EEQ of 1.5 (95%CI−0.2–3.2)pg/ml. For the associations between the recent use of
disinfectants and plasma EEQs and AEQs, more convincing effect estimates were
calculated: beta 2.1 (95%CI 0.2–3.9)pg/ml and beta 1.6 (95%CI 0.3–3.5)×10−1 ng/ml,
respectively. Disinfectants mostly involved cleaning hands or equipment with alcohol,
whichwas reported bymenwith very diverse job titles. Occupational exposure to organic
Table 2
Estimated effects of general determinants and exposure variables on estrogenic (EEQ) and androgenic (AEQ) activities as measured by CALUX® in total plasma.
n EEQ pg/ml AEQ×10−1 ng/ml
Betaa Adj. beta (95%CI)b Betaa Adj. beta (95%CI)b
Ethnic origin
European Caucasian 104 Ref Ref Ref Ref
Other 4 −2.5 −1.7 (−4.9–1.5)c 3.7 3.1 (0.1–6.2)d
Age
25–39 40 Ref Ref Ref Ref
40–44 45 0.1 0.1 (−1.2–1.3) 0.1 0.4 (−0.8–1.5)e
45–55 22 0.9 1.0 (−0.7–2.4) 0.8 1.3 (−0.2–2.7)e
BMI
b25 38 Ref Ref Ref Ref
25–30 56 0.8 0.7 (−0.4–1.9)f −0.5 −0.4 (−1.5–0.8)e
≥30 14 1.3 0.8 (−1.0–2.7)f −1.9 −1.3 (−3.1–0.4)e
Weight loss of ≥10 kg
No 82 Ref Ref Ref Ref
N2 years ago 19 −0.8 −0.8 (−2.3–0.7) −0.6 −0.6 (−2.0–0.9)
Within past 2 years 7 0.5 0.5 (−1.8–2.7) −0.7 −0.7 (−2.9–1.6)
Smoking
No 79 Ref Ref Ref Ref
5–6 cigarettes per day 6 1.7 1.7 (−0.7–4.2) 0.1 −0.4 (−2.7–1.9)g
10–15 cigarettes per day 15 0.0 0.0 (−1.6–1.7) 2.5 1.9 (0.1–3.6)g
20–30 cigarettes per day 8 −0.4 −0.4 (−2.6–1.7) 2.4 1.9 (−0.1–4.0)g
Alcohol consumption
0–6 glasses per week 56 Ref Ref Ref Ref
7–15 glasses per week 36 0.1 0.1 (−1.1–1.3) 0.4 0.5 (−0.7–1.7)e
20–50 glasses per week 16 0.3 0.3 (−1.4–2.0) 1.4 1.4 (0.2–3.1)e
Prescriptive drug use
No 82 Ref Ref Ref Ref
Yes 26 1.5 1.5 (0.2–2.8) −0.6 −0.2 (−1.4–1.1)h
Use of personal care products
No 24 Ref Ref Ref Ref
1–2 products 68 −0.4 −0.3 (−1.7–1.0)i 0.3 0.3 (−1.0–1.6)j
≥3 products 16 −1.4 −1.2 (−3.0–0.7)i −1.0 −1.4 (−3.3–0.4)j
Lives within city centre
No 101 Ref Ref Ref Ref
Yes 7 −0.7 −0.3 (−2.5–2.0)k 0.3 0.3 (−1.9–2.6)
a Adjusted for time of blood draw.
b Adjusted for time of blood draw and other confounders:
c BMI, smoking, prescriptive drug use, personal care products, and occupational exposures (any).
d Smoking and alcohol consumption.
e Ethnic origin and smoking.
f Prescriptive drug use.
g Ethnic origin and alcohol consumption.
h Ethnic origin, BMI, and smoking.
i Ethnic origin.
j Ethnic origin, age, and smoking.
k Ethnic origin, BMI, and occupational exposures (any).
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be linkedwith a slightly increased plasma EEQ: beta 1.3 (95%CI−0.3–3.0)pg/ml, whereas
no elevated of reduced EEQs or AEQs were noted in 31 men with exposures to these
products from leisure time activities (e.g. home improvements or hobbies). Men who
reportedexposure toweldingor soldering fumesseemedtohave somewhathigherplasma
AEQs: beta 1.4 (95%CI−0.2–2.9)×10−1 ng/ml.Working with copper or lead or exposure
to fumes from plastics could not be associated with EEQs or AEQs in plasma. An
approximately 30% higher plasma EEQ was found in six men with indoor exposure to
vehicle exhaust fumes for at least 5h/week: beta 2.9 (95%CI 0.6–5.2)pg/ml.
Effect estimates of dietary intake variables are presented in Table 4. Plasma EEQs
and AEQs could not be associated with the current intake frequency of any food item.
The DR CALUX® measurements, however, revealed that men with TEQs over 60 pg/g
lipids, which represent moderate to high internal levels of total dioxins, had
approximately 20% higher plasma AEQs compared to men with TEQs below 50 pg/g
lipids (Table 5).4. Discussion
In this observational study, we explored the effects of exposure to
a variety of sources of potential endocrine disruptors on total
estrogenic and androgenic plasma activities measured by CALUX®
bioassays. To our knowledge, this is the ﬁrst study in which the
CALUX® technology was used to assess hormone activities in total
plasma, in contrast to previous reports in which measurements wereperformed on plasma extracts of speciﬁc lipophilic pollutants. The
total estrogenic and androgenic activities in plasma would reﬂect
receptor activation by any prevalent xenobiotics, as well as by
endogenous hormones (Fig. 1), also detecting certain ‘indirect’ effects
of xenobiotics, such as interference with the bioavailability of
endogenous hormones or competitive receptor binding. Therefore,
we hypothesized that the CALUX® measurements in total plasma
would represent biologically relevant summary estimates for internal
exposures to endocrine disruptors.
In summary, we detected differences in the estrogenic and/or
androgenic activities between categories of ethnic origin (crudely
classiﬁed as ‘European Caucasian’ vs. ‘other’), age, smoking, alcohol
consumption, and prescriptive drug use. The data also indicated
associations between several occupational exposures and increased
plasma estrogenicity and/or androgenicity, whereas no associations
with the intake of speciﬁc food items were found. Finally, positive
associations were found between internal dioxin levels (TEQs) and
androgenic plasma activity. Before interpreting these results, we
return to some methodological issues concerning the study design,
methods, and analyses that may have inﬂuenced our ﬁndings.
The study population was recruited among fathers who partici-
pated in a case–referent study on hypospadias and cryptorchidism, so
Table 3
Estimated effects of occupational exposures on estrogenic (EEQ) and androgenic (AEQ) activities as measured by CALUX® in total plasma.
n EEQ pg/ml AEQ×10−1 ng/ml
Betaa Adj. beta (95%CI)b Betaa Adj. beta (95%CI)b
Any self-reported exposures
No 34 Ref Ref Ref Ref
Yes 74 1.2 1.2 (−0.1–2.4) 0.7 0.7 (−0.5–1.9)
Pesticides
No 34 Ref Ref Ref Ref
N4 weeks ago 11 1.0 1.0 (−0.7–2.8) 2.0 1.6 (−0.5–3.6)c
≤4 weeks ago 12 1.5 1.5 (−0.2–3.2) −0.1 −0.2 (−2.1–1.8)c
Disinfectants
No 34 Ref Ref Ref Ref
N1 week ago 18 0.9 0.9 (−0.7–2.4) 0.5 0.5 (−1.1–2.1)d
≤1 week ago 12 2.1 2.1 (0.2–3.9) 1.1 1.6 (0.3–3.5)d
Industrial cleaning agents, solvents, paint, ink, adhesives, and thinners
No 34 Ref Ref Ref Ref
N1 week ago 13 0.8 0.6 (−1.4–2.6)e 1.1 1.1 (−0.9–3.1)
≤1 week ago 24 1.1 1.3 (−0.3–3.0)e 1.0 1.0 (−0.7–2.6)
Fumes from welding or soldering
No 34 Ref Ref Ref Ref
N1 week ago 6 1.2 1.7 (−0.9–4.2)f 0.3 0.7 (−1.3–2.7)g
≤1 week ago 11 0.5 0.5 (−1.4–2.4)f 1.1 1.4 (−0.2–2.9)g
Copper or lead
No 34 Ref Ref Ref Ref
N4 weeks ago 3 1.4 1.4 (−1.8–4.5) 0.1 0.1 (−2.7–2.8)
≤4 weeks ago 10 0.7 0.7 (−1.2–2.6) −0.7 −0.7 (−2.3–1.0)
Fumes from plastics
No 34 Ref Ref Ref Ref
Yes 8 0.7 0.7 (−1.5–2.9) 0.5 0.5 (−1.3–2.3)
Exhaust fumes (indoors for at least ﬁve hours per week)
No 34 Ref Ref Ref Ref
Yes 6 2.1 2.9 (0.6–5.2)h 0.1 0.1 (−2.0–2.1)
N.B. For each of the occupational exposure variables, the reference category was restricted to fathers who did not report occupational exposure to any of the exposure categories
(n=34).
a Adjusted for time of blood draw.
b Adjusted for time of blood draw and other confounders:
c Alcohol consumption.
d BMI and smoking.
e BMI and age.
f Private use of personal care products.
g Ethnic origin.
h Age and private use of personal care products.
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Theoretically, a problem could arise if in these fathers, the effects of
chemical exposures on plasma hormone activity would substantially
differ from other men, but this seems unlikely. However, the fact that
all men had fathered children could imply that men with reduced
fertility (possibly associated with exposure to endocrine disruptors)
were somewhat underrepresented in our population.
With the population recruitment strategy, we aimed to obtain a
sufﬁcient exposure gradient to identify differences in plasma
hormone activities between high and low exposure categories for
different sources of potential endocrine disruptors. As a consequence,
the reference category of a particular exposure variable may include
many subjects that reported other sources of potential endocrine
disruptors, which could bias the effect estimate. Although we tried to
adjust for confounding by other exposure sources with multivariable
analyses, residual confounding cannot be ruled out, especially when
the population size did not allow adjustment for multiple variables
simultaneously. This may have led to both underestimated and
overestimated effect estimates. The effect estimates may also be
affected by exposure misclassiﬁcation, which most likely resulted in
bias towards the null. Overall, the ﬁndings of this explorative study
should be interpretedwith caution and require conﬁrmation by future
research.
The elevated plasma androgenic activity associated with increased
age was unexpected. Increasing age is known to be accompanied by a
decline in endogenous free testosterone (Allen et al., 2002; Muller
et al., 2003; Svartberg et al., 2003; Orwoll et al., 2006). Therefore, itseems that our ﬁndings result from differences in environmental
factors, rather than in endogenous hormone levels, between different
ages. We speculate that life-long exposure to persistent endocrine
disruptors in older men could explain the association, because we
found a positive association between internal dioxin levels and
plasma androgenic activity.We could not link age with internal dioxin
levels, but other investigators have done so (Warner et al., 2005;
Dhooge et al., 2006).
A relatively strong association was found between smoking and
plasma androgenic activity, which increased with approximately 20%.
Smoking has been reported to increase serum Sex Hormone Binding
Globulin (SHBG) and total testosterone levels, but no clear differences
in bioavailable testosterone were seen (English et al., 2001). Tobacco
smoke consists of a mixture of endocrine disrupting toxicants, such as
PAHs (Arcaro et al., 1999) and cadmium (Henson and Chedrese,
2004). Possibly, these chemicals are able to directly activate androgen
receptors without altering the level of endogenous bioavailable
testosterone. The increased androgenic activity associated with
alcohol consumption also seems unlikely to result from elevated
endogenous testosterone (Svartberg et al., 2003) and could reﬂect a
receptor-activating potential of e.g. ethanol, phytoestrogens, or other
constituents. Based on the current data, however, we can only
speculate about the explanations for the increased androgenic plasma
activities in smokers and heavy drinkers.
The effect estimates for the use of personal care products were
inconclusive. Many personal care products contain a mixture of
phthalates, parabens, solvents, and UV screens, for which different
Table 4
Estimated effects of dietary intake variables on the estrogenic (EEQ) and androgenic (AEQ) activities as measured with CALUX® in total plasma.
n EEQ pg/ml AEQ×10−1 ng/ml
Betaa Adj. beta (95%CI)b Betaa Adj. beta (95%CI)b
Beef or pork
b3× per week 21 Ref Ref Ref Ref
3–5× per week 59 0.1 0.1 (−1.3–1.6) 1.2 0.7 (−0.8–2.1)c
6–7× per week 27 −0.2 −0.2 (−1.9–1.5) 1.0 0.8 (−0.8–2.3)c
Chicken
b1× per week 30 Ref Ref Ref Ref
1–5× per week 63 −0.8 −0.6 (−1.9–0.6)d −0.1 −0.1 (−1.3–1.1)e
6–7× per week 15 −1.3 −0.8 (−2.7–1.1)d 0.9 0.6 (−1.2–2.4)e
Fish and seafood
b1× per week 35 Ref Ref Ref Ref
1–2× per week 65 −0.3 −0.2 (−1.2–1.2)d 0.4 0.4 (−0.8–1.6)
3–7× per week 8 −0.2 0.4 (−1.9–2.7)d 1.0 1.0 (−1.3–3.3)
Dutch fried meat snacks
b1× per week 35 Ref Ref Ref Ref
1–7× per week 73 −0.3 −0.3 (−1.5–0.9) 0.5 0.5 (−0.7–1.7)
Eggs
b1× per week 14 Ref Ref Ref Ref
1–2× per week 80 −0.3 −0.3 (−2.0–1.4) −1.5 −1.1 (−2.7–0.6)f
3–7× per week 12 0.4 0.4 (−1.9–2.7) −0.7 −0.5 (−2.7–1.8)f
Dairy (cheese, yoghurt, milk)
1–2× per week (on average) 29 Ref Ref Ref Ref
3–5× per week (on average) 41 −0.1 −0.1 (−1.5–1.3) −0.6 −0.6 (−2.0–0.8)
6–7× per week (on average) 38 0.5 0.5 (−0.9–2.0) 0.3 0.3 (−1.7–1.1)
Soy replacements of meat or milk
b1× per week 103 Ref Ref Ref Ref
≥1× per week 5 −1.2 −1.2 (−3.9–1.4) −0.2 −1.1 (−3.7–1.4)g
a Adjusted for time of blood draw.
b Adjusted for time of blood draw and other confounders:
c Ethnic origin and smoking.
d Occupational exposures (any).
e Ethnic origin, smoking, and occupational exposures (any).
f Ethnic origin, smoking, and alcohol consumption.
g Ethnic origin, BMI, and smoking.
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2001; Harvey and Darbre, 2004; Main et al., 2006). In order to draw
conclusions about the effects of personal care products on the total
plasma androgenic and estrogenic activities, a more detailed exposure
assessment method is required. A different population recruitment
strategy that would capture men with higher exposure levels could
give more insight into the effects of personal care products as well.
Due to small numbers, we could not reliably assess the effects of
regular consumption of phytoestrogens in soy. For the intake of animal
fats, which are sources of persistent endocrine disrupting chemicals
(Bilau et al., 2008), no associations with estrogenic or androgenic
activitieswere found. Comparing thedata on current dietary habitswith
theDRCALUX®measurements provided some indications for increased
internal dioxin levels amongmenwith high intakes of chicken and eggs
(Supplemental Table 1). But the intake of beef, pork, and dairy products
seemed to be inversely associated with plasma TEQs, which was
unexpected. We examined confounding by other determinants includ-
ing the other dietary intake variables and hypothesized that a high
intake of chicken or eggs could be associated with a low intake of beefTable 5
Estimated effects of internal dioxin levels (TEQ) on total estrogenic (EEQ) and
androgenic (AEQ) activities measured with CALUX® in total plasma.
n EEQ pg/ml AEQ×10−1 pg/ml
Beta (95%CI)a Betaa Adj. beta (95%CI)b
Internal dioxin level
32.5–50.0 TEQ pg/g lipid 22 Ref Ref Ref
50.1–60.0 TEQ pg/g lipid 13 −0.4 (−2.5–1.6) 0.3 0.7 (−1.3–2.8)
60.1–85.0 TEQ pg/g lipid 15 0.2 (−1.7–2.2) 2.1 2.4 (0.5–4.3)
a Adjusted for time of the blood draw.
b Adjusted for time of the blood draw and age.and pork or dairy, resulting in the inverse associations. After adjustment
for intake of chicken and eggs, however, even smaller betaswere found.
These ﬁndings were probably affected by exposure misclassiﬁcation, as
the questionnaire provided only crude estimates for dietary intake. For
example, we could not account for differences in chemical exposure
between different types of ﬁsh and between ﬁsh captured from wild
ﬁsheries or harvested in ﬁsh farms. In addition, only current dietary
habits were assessed, which could differ from dietary habits in the past
that would also have contributed to the body burden at time of study.
Due to these limitations, wemay not have been able to detect endocrine
disrupting effects of dietary sources of persistent chemical exposures.
We also assessed associations between the DR CALUX®measurements
and other potential determinants for internal exposure to persistent
endocrine disrupting chemicals, including age, BMI, weight loss, and
living within a city centre, but the effect estimates were inconclusive
(Supplemental Table 2).
We did, however, identify a positive association between plasma
androgenic activity and the internal dioxin TEQ values over a small
range (Table 5). An inverse association between CALUX® TEQs and
total and free testosterone in male serum has been reported (Dhooge
et al., 2006), as well as between CALUX® TEQs and AEQs in fetal
plasma after MTBE extraction (R=−0.7) (Pedersen et al., 2010).
Pliskova and colleagues measured a reduced estrogenic activity in
male serum extracts containing high levels of PCBs, which seemed to
be associated with a decline in endogenous estradiol (Pliskova et al.,
2005). In our study, plasma TEQs were not associated with reduced
estrogenic activity in total plasma, but this could also be due to the
lower exposure levels.
Estrogenic and/or androgenic plasma activities seemed to be
increased in men occupationally exposed to disinfectants, pesticides,
welding or soldering, and vehicle exhaust fumes. These exposures
occurred in very diverse occupational settings and often involved
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groups was very common, it was difﬁcult to attribute differences in
estrogenic or androgenic activities to speciﬁc exposures. In general,
multivariable analyses with adjustment for co-exposures did not
drastically change the effect estimates. However, reliable estimation
of the independent effects of disinfectants, pesticides, welding or
soldering, exhaust fumes, and other occupational exposures, requires
a larger population size that allows more speciﬁc exposure classiﬁ-
cation. We interpret the present ﬁndings as indications that various
occupational exposures can alter estrogenic or androgenic activities
and are therefore potentially relevant sources of endocrine disruptors.
As pointed out, further research is needed to elucidate the effects of
different sources of endocrine disruptors on the estrogenic and
androgenic plasma activities inmen. Including internalmeasurements
of certain groups of chemicals such as dioxins in future research, could
clarify their speciﬁc role in the estrogenic and androgenic activities
found, especially if these chemicals have long half-lives of excretion. In
addition, measurements of endogenous estradiol and testosterone
levels could give more insight into the mechanisms through which
estrogenicity or androgenicity in total plasma are inﬂuenced by
chemical exposures. An experimental study design could clarify the
rapid effects of phytoestrogens on estrogenic and androgenic plasma
activities. Research also needs to be extended to both males and
females of different age groups, who have speciﬁc hormone proﬁles
and may therefore respond differently to chemical exposures.
5. Conclusions
The results of this explorative study are not yet readily interpret-
able. However, they demonstrate that it is possible to identify
associations between sources of potential endocrine disruptors and
measurements of estrogenic and androgenic activities in total plasma
among a reasonably sized group of men. Because the total estrogenic
and androgenic plasma activities reﬂect receptor activation by any
xenobiotics present as well as by endogenous hormones, they also
capture indirect effects such as interference with the bioavailability of
endogenous hormones or competitive receptor binding. Comparing
thesemeasurements with ﬁndings regarding the levels of endogenous
hormones or with internal measurements of speciﬁc chemicals or
chemical derivatives could clarify the endocrine disrupting potential
of certain chemicals as well as their behavior within the human body.
Measurements of total estrogenic and androgenic plasma activities
could thereby help to better understand associations between
potential exposure sources of endocrine disruptors and speciﬁc health
outcomes in epidemiological studies.
Abbreviations
AEQ androgen equivalent
AhR arylhydrocarbon receptor
AR androgen responsive
BMI body mass index
CALUX chemically activated luciferase gene expression
DHT dihydrotestosterone
EEQ estrogen equivalent
ER estrogen responsive
MTBE methyl tert-butyl ether
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